OTCMKTSMKTS:CDXI

Cardax Stock Forecast, Price & News

Add
Compare
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Cardax, Inc., a biopharmaceutical company, develops and commercializes dietary supplements for inflammatory health and pharmaceuticals for chronic diseases driven by inflammation and oxidative stress. It offers ZanthoSyn, an anti-inflammatory supplement for health and longevity that provides astaxanthin with enhanced absorption and purity. The company sells ZanthoSyn primarily through e-commerce and wholesale channels. It is also developing CDX-101, an astaxanthin pharmaceutical candidate; and CDX-301, a zeaxanthin pharmaceutical candidate for pharmaceutical applications. The company has a joint development and supply agreement with BASF SE, as well as a collaboration agreement with Capsugel US, LLC for the development of astaxanthin products for the consumer health market. Cardax, Inc. is based in Honolulu, Hawaii.

Industry, Sector and Symbol

Stock Exchange OTCMKTSMKTS
Industry Biotechnology
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTSMKTS:CDXI
CUSIPN/A
CIKN/A
Phone808 457 1400
EmployeesN/A
Year FoundedN/A

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

Next Earnings DateN/A
OptionableNot Optionable

Headlines

No headlines for this company have been tracked by MarketBeat.com

MarketRank

Overall MarketRank

0.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 0.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
30 days | 90 days | 365 days | Advanced Chart

Receive CDXI News and Ratings via Email

Sign-up to receive the latest news and ratings for CDXI and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Cardax (OTCMKTSMKTS:CDXI) Frequently Asked Questions

What stocks does MarketBeat like better than Cardax?

Wall Street analysts have given Cardax a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Cardax wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Who are Cardax's key executives?

Cardax's management team includes the following people:
  • Mr. David G. Watumull, Pres, CEO & Director (Age 71, Pay $198.65k)
  • Mr. David M. Watumull, COO, Sec. & Assistant Treasurer (Age 39, Pay $156.22k)
  • Dr. Gilbert M. Rishton Ph.D., Chief Science Officer
  • Mr. John B. Russell CPA, CPA, CFO & Treasurer (Age 48)
  • Mr. Gilbert Shin, VP of Retail Sales & Marketing
  • Dr. Jon L. Ruckle, Chief Medical Officer

Who are some of Cardax's key competitors?

What is Cardax's stock symbol?

Cardax trades on the OTCMKTSMKTS under the ticker symbol "CDXI."

How do I buy shares of Cardax?

Shares of CDXI can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

How many employees does Cardax have?

Cardax employs 11 workers across the globe.

What is Cardax's official website?

The official website for Cardax is www.cardaxpharma.com.

How can I contact Cardax?

The company can be reached via phone at 808 457 1400.


This page was last updated on 4/11/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.